Insider Shareholders with Direct Ownership of Rhythm Pharmaceuticals, Inc. (RYTM)
This section provides a comprehensive overview of the insiders with direct ownership of Rhythm Pharmaceuticals, Inc. (RYTM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RHYTHM PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David P Meeker
President and CEO |
123,125 | 49,855 | 174,605 $9.75 Million | 5 |
Mar 19, 2024
Reduced 20.67%
|
|
Hunter C Smith
Chief Financial Officer |
150,333 | 82,029 | 97,939 $5.47 Million | 29 |
Mar 19, 2024
Reduced 13.68%
|
|
Yann Mazabraud
EVP, Head of International |
46,720 | 32,585 | 34,870 $1.95 Million | 13 |
Apr 14, 2024
Reduced 22.93%
|
|
Pamela J. Cramer
Chief Human Resources Officer |
111,401 | 100,390 | 13,500 $753,975 | 26 |
Nov 07, 2024
Reduced 25.78%
|
|
William T. Roberts
Chief Accounting Officer |
7,313 | 2,894 | 7,872 $439,651 | 6 |
Mar 29, 2023
Reduced 10.38%
|
|
Camille L Bedrosian
Director |
3,000 | 0 | 3,000 $167,550 | 1 |
Jun 21, 2024
Added 50.0%
|
| 3,000 | 0 | 3,000 $167,550 | 1 |
Jun 21, 2024
Added 50.0%
|
|
|
Stuart A Arbuckle
Director |
3,000 | 0 | 3,000 $167,550 | 1 |
Jun 21, 2024
Added 50.0%
|
|
Jennifer L Good
Director |
86,500 | 83,500 | 3,000 $167,550 | 7 |
Sep 17, 2024
Reduced 91.37%
|
|
David W J Mcgirr
Director |
3,000 | 0 | 3,000 $167,550 | 1 |
Jun 21, 2024
Added 50.0%
|
|
Lynn A. Tetrault
Director |
38,000 | 35,000 | 3,000 $167,550 | 9 |
Sep 10, 2024
Reduced 10.45%
|
|
Christophe Jean
Director |
3,000 | 0 | 3,000 $167,550 | 1 |
Jun 21, 2024
Added 50.0%
|
|
Jennifer Chien
EVP, Head of North America |
148,302 | 148,304 | 972 $54,286 | 31 |
Nov 11, 2024
Reduced 17.06%
|
|
Christopher Paul German
Corporate Controller & CAO |
1,163 | 368 | 795 $44,400 | 2 |
Apr 02, 2024
Reduced 31.64%
|
|
Joseph Shulman
Chief Technical Officer |
187,015 | 186,975 | 0 $0 | 31 |
Nov 11, 2024
Reduced 100.0%
|